Zacks Investment Research on MSN
Organon secures FDA approval extending NEXPLANON use to five years
Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
The U.S. Food and Drug Administration (FDA) has approved a label expansion for Nexplanon to allow its manufacturer, Organon (OGN), to market the birth control implant, indicating an efficacy duration ...
Nexplanon (etonogestrel) is a brand-name birth control implant prescribed to help prevent pregnancy. Nexplanon has interactions with some other drugs and certain herbal supplements. Examples include ...
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US ...
Nexplanon is a birth control device. It’s approved to help prevent pregnancy, so you should not use it during pregnancy. It’s important to note that no birth control is 100% effective at preventing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results